Compara mètodes

	Escala PedMIDAS de Discapacitat per Migranya Pediàtrica	Cuestionario de Calidad de Vida en Asma Pediátrica (PAQLQ)	Mòdul PedsQL de Diabetis
Camp	Pediatria	Pediatria	Pediatria
Família	Process / pipeline	Process / pipeline	Process / pipeline
Any d'origen	2001	1996	2003
Autor original	Amy D. Hershey	E. F. Juniper	James W. Varni
Tipus	Parent-report and/or child self-report of missed activities	Child self-report; parent version available	Child self-report and parent proxy
Font seminal	Hershey, A. D., Powers, S. W., Vockell, A. L., LeCates, S., & Ellinwood, E. H. (2001). PedMIDAS: Development of a questionnaire to assess disabilities in migrainous children. Headache, 41(6), 556-563.	Juniper, E. F., Guyatt, G. H., Feeny, D. H., Ferrie, P. J., Griffith, L. E., & Townsend, M. (1996). Measuring quality of life in children with asthma. Quality of Life Research, 5(1), 35-46.	Varni, J. W., Burwinkle, T. M., Jacobs, J. R., Gottschalk, M., Kaufman, F., & Jones, K. L. (2003). The PedsQL in type 1 and type 2 diabetes: Reliability and validity of the Pediatric Quality of Life Inventory Generic Core Scales and type 1 Diabetes Module. Diabetes Care, 26(3), 631-637.
Àlies	Pediatric Migraine Disability Assessment, MIDAS, MIDAS Pediatric	PAQLQ-S	PedsQL 3.0 Diabetes
Relacionats	4	4	5
Resum	The PedMIDAS is a brief 6-item parent-report (with child input for older youth) instrument developed by Hershey et al. in 2001 to quantify migraine-related functional disability in children and adolescents. Rather than measuring pain intensity or headache frequency, the PedMIDAS focuses on the ultimate impact of migraine on daily life: how many days of school, sports/play, and family activities does the child miss or participate in only with significant limitation? This outcome-focused approach makes it particularly useful for assessing the real-world burden of migraine in children and evaluating treatment effectiveness.	The PAQLQ is a 23-item self-report instrument developed by Juniper et al. in 1996 to measure quality of life in children aged 7–17 years with asthma. It assesses how asthma and its treatment affect daily functioning, emotions, and activity levels. The instrument has become the gold standard for evaluating asthma-specific health-related quality of life in pediatric populations.	The PedsQL Diabetes Module is a 28-item disease-specific instrument developed by Varni et al. in 2003 to measure quality of life in children and adolescents with type 1 and type 2 diabetes. It captures the impact of diabetes management, glucose monitoring, and disease-related worry on daily functioning. The module is paired with the PedsQL Generic Core Scales, enabling both disease-specific and general health-related quality of life assessment.